Counter-Detailing Anti-drug Reps Coming to Educate Doctors
The question is can these visits overcome industry's propaganda delivered under the guise of continuing medical education (CME) courses which physicians must take?
Netracor J & J heart Drug May Raise Risk of Dying
Netracor J & J heart Drug May Raise Risk of Dying Wed, 20 Apr 2005 A new research challenges the safety level linked with the drug ‘Natretor.’ Scios Inc., a subsidiary of Johnson & Johnson is the maker of “Natrecor.” “Researchers say that the use of heart-failure drug Natrecor results…
Suspended Chief Medical Officer of Medicare reassigned to AHRQ
Suspended Chief Medical Officer of Medicare reassigned to AHRQ Wed, 21 Sep 2005 An example of how little the federal government cares about professinal standards or the integrity of high ranking medical offficers. Contact: Vera Hassner Sharav 212-595-8974 Daily Health Policy Report Kaiser Network Suspended CMS Chief Medical Officer Tunis…
When Doctors Learn, Drug Firms Often Pay the Tab – Philly Inquirer
When Doctors Learn, Drug Firms Often Pay th eTab – Philly Inquirer Wed, 8 Jun 2005 The Philadelphia Inquirer reports about the blinders that academic medical institutions and physicians (in this instance psychiatrists) put on pretending not to know that they have surrendered the integrity of medicine and medical education…
Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry– Multi-Discipline Conference_ NYC
Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry– Multi-Discipline Conference_ NYC Mon, 4 Oct 2004 An Op Ed article in The Washington Post by Shannon Brownlee (below) nails the elite procurers of psychotropic drugs who have long denied the ominous signals of drug-induced harm: “You’d think the psychiatric research…
When Doctors Go to Class, Industry Often Foots the Bill – WSJ
When Doctors Go to Class, Industry Often Foots the Bill – WSJ Fri, 6 Dec 2002 A front page article in The Wall Street Journal by Scott Hensley sheds further light on the corruption of medical ethics by focusing on a drug marketing ploy that is promoted as “continuing medical…
Almost 1/2 of faculty on IRBs have ties to industry – Harvard Partners
Almost 1/2 of faculty on IRBs have ties to industry – Harvard Partners Fri, 15 Aug 2003 A survey by faculty at the Institute for Health Policy, Massachusetts General Hospital (MGH) and Harvard Medical School found that “Consulting relationships with industry are common among faculty IRB members….Our previous research with…
Harvard / Stanford–Psychiatrists’ Financial Ties to Industry
Two probing first rate investigative reports document how psychiatry’s treatments are shaped by "opinion leaders" whose professional recommendations are compromised by their substantial, largely undisclosed, financial ties to drug companies.
NEJM Vioxx Safety Correction / Consumers International Accuses Industry–Unscrupulous Marketing
Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
Pharma company Influence Medical Education Promotes OffLabel Use of Antipsychotic
Psychiatry’s professional practice paradigm has received a major blow.
Doctors Back Ban on Gifts From Drug Makers_Journal Hypocrisy
"32% of the advertisements [in peer reviewed journals] misled readers regarding efficacy, 40% did not provide balanced descriptions of the side effects, and 44% could lead to improper prescribing if the physician did not use other sources of information regarding the drug."
Panel Urges Academia to BAN Drug Marketing
Correction! A panel calling itself the Institute of Medicine as a Profession (IMP) is calling for a ban on the intermingling of industry and academic scholars and physicians. This is NOT affiliated with the Institute of Medicine (IOM)